Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LDL Hyperlipoproteinemia”

165 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 165 results

Post-approval studies (Phase 4)Study completedNCT00916643
What this trial is testing

Low-Density Lipoprotein (LDL) Apheresis Using H.E.L.P. Therapy

Who this might be right for
Familial Hypercholesterolemia
B. Braun Medical Inc. 113
Not applicableStudy completedNCT00536965
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 951
Not applicableStudy completedNCT04148001
What this trial is testing

Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)
REGENXBIO Inc. 4
Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,012
Testing effectiveness (Phase 2)Study completedNCT02659397
What this trial is testing

Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg

Who this might be right for
Hyperlipidemia
Esperion Therapeutics, Inc. 68
Large-scale testing (Phase 3)Ended earlyNCT00231621
What this trial is testing

A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia

Who this might be right for
ObesityHyperlipidemiaHypertriglyceridemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 179
Post-approval studies (Phase 4)Looking for participantsNCT06789432
What this trial is testing

Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population

Who this might be right for
Hyperlipidemia (E.G., Hypercholesterolemia)
Dr. Md. Alimur Reza 500
Not applicableUnknownNCT03152656
What this trial is testing

A Registration Study for Familial Hypercholesterolemia in Taiwan

Who this might be right for
Familial Hypercholesterolemia
National Taiwan University Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT00810979
What this trial is testing

Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Response Pharmaceuticals 133
Testing effectiveness (Phase 2)Study completedNCT00559962
What this trial is testing

Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS

Who this might be right for
Hyperlipidemia
Aegerion Pharmaceuticals, Inc. 260
Large-scale testing (Phase 3)Looking for participantsNCT06597006
What this trial is testing

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia - Homozygous
Novartis Pharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT03814187
What this trial is testing

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

Who this might be right for
ASCVDElevated CholesterolHeterozygous Familial Hypercholesterolemia+1 more
Novartis Pharmaceuticals 3,275
Not applicableStudy completedNCT00536796
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 1,096
Testing effectiveness (Phase 2)Study completedNCT00519363
What this trial is testing

Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors

Who this might be right for
Systemic Lupus Erythematosus
The Center for Rheumatic Disease, Allergy, & Immunology 15
Early research (Phase 1)Looking for participantsNCT06164730
What this trial is testing

VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Who this might be right for
Heterozygous Familial HypercholesterolemiaPremature Coronary Heart Disease
Verve Therapeutics, Inc. 85
Not applicableStudy completedNCT06154408
What this trial is testing

Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms

Who this might be right for
LDL HyperlipoproteinemiaLow-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaTriglyceride Storage Type I or II Disease
S.LAB (SOLOWAYS) 102
Not applicableUnknownNCT00331448
What this trial is testing

Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults

Who this might be right for
HIV InfectionsLipodystrophyDiabetes+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 1,483
Large-scale testing (Phase 3)Study completedNCT02226198
What this trial is testing

Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)
AstraZeneca 20
Not applicableStudy completedNCT06910098
What this trial is testing

Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels

Who this might be right for
LDL - Low Density Lipoprotein Receptor DisorderRosuvastatin
Central Park Medical College 195
Testing effectiveness (Phase 2)Ended earlyNCT01004705
What this trial is testing

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Who this might be right for
Elevated LDL Cholesterol
Ferrer Internacional S.A. 36
Load More Results